Kamal Hamed, Chief Medical Officer: Spero Therapeutics SPRO Sell · Filed 24/02/05

Trade details

Type: Insider sale
Amount: $38,462.75
Shares · price: 28,075 sh · $1.37 a share
Held after: 788,117 sh
Stock: Spero Therapeutics SPRO
Person: Kamal HamedChief Medical Officer
Trade date: 24/02/02
Filed: 24/02/05
Days to filing: 3 days

Sold 3.4% of holdings

Share of holding sold: 3.4%

Spero Therapeutics trades, last 26 weeks

What else happened in Spero Therapeutics around then

Filed or reported within 30 days of the trade day · 24/01/03~24/03/03

Kamal Hamed's recent trades

Kamal HamedChief Medical Officer
SellSpero Therapeutics
Sell
Spero Therapeutics
SPRO
$50.2K
39,496 sh
$50.2K
Filed 23/09/15
Traded 23/09/13

Kamal Hamed, Chief Officer — sold $38.5K of Spero Therapeutics SPRO · 3.4% of holdings | Whalegun